Atara biotherapeutics stock price

Stock analysis for Atara Biotherapeutics Inc (ATRA:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Atara Biotherapeutics, Inc. - ATRA - Stock Price Today - Zacks

Stock Comparison: Compare Atara Biotherapeutics, Inc ... Online Stock Comparison - Compare Atara Biotherapeutics, Inc. (ATRA) to four other stocks with NASDAQ.com's stock comparison tool. Atara Biotherapeutics Inc - ATRA - Stock price forecast May 30, 2019 · ATRA stock forecast Our latest prediction for Atara Biotherapeutics, Inc.'s stock price was made on the May 30, 2019 when the stock price was at 22.78$. In the short term (2weeks), ATRA's stock price should outperform the market by 1.14%. During that period the price should oscillate between -9.09% and +14.55%. ATRA - Atara Biotherapeutics Summary, Stock ... - Benzinga Jan 01, 2010 · Atara Biotherapeutics (NASDAQ: ATRA) stock research, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings, guidance and peers

Atara Biotherapeutics, Inc. (ATRA) Stock Historical Prices ...

Real time Atara Biotherapeutics (ATRA) stock price quote, stock graph, news & analysis. ATRA:NASDAQ GS Stock Quote - Atara Biotherapeutics Inc ... Stock analysis for Atara Biotherapeutics Inc (ATRA:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Atara Biotherapeutics, Inc. - ATRA - Stock Price Today - Zacks View Atara Biotherapeutics, Inc. ATRA investment & stock information. Get the latest Atara Biotherapeutics, Inc. ATRA detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Atara Biotherapeutics, Inc. Common Stock (ATRA) Analyst ... Mar 27, 2020 · Atara Biotherapeutics, Inc. Common Stock (ATRA) Analyst Research. ATRA Analyst Ratings. The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00.

Atara Biotherapeutics, Inc. Common Stock (ATRA) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.

In depth view into ATRA (Atara Biotherapeutics) stock including the latest price, news, dividend history, earnings information and financials.

ATRA: Atara Biotherapeutics, Inc. - Price and Consensus Chart. Get the latest Price and Consensus Chart for Atara Biotherapeutics, Inc. from Zacks Investment Research

Atara... (ATRA) Stock Quote | Price Chart | Volume Chart View a financial market summary for ATRA including stock price quote, trading volume, volatility, options volume, statistics, and other important company data related to ATRA (Atara Biotherapeutics Inc.) stock. Atara Biotherapeutics Reports Inducement Grants Under ... Atara is providing this information in accordance with Nasdaq Listing Rule 5635(c)(4). About Atara Biotherapeutics, Inc. Atara Biotherapeutics, Inc. is a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with cancer, autoimmune and viral diseases. Atara’s technology platform leverages ATRA -- Is Its Stock Price A Worthy Investment? Learn More. Atara Biotherapeutics is a biopharmaceutical company focused on developing innovative therapies for patients with debilitating diseases. The company was founded in 2012 and is based in South San Francisco, California.

ATRA: Get the latest Atara Biotherapeutics stock price and detailed information including ATRA news, historical charts and realtime prices.

Stock analysis for Atara Biotherapeutics Inc (ATRA:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company 

ATRA Real Time Stock Quote - Get Atara Biotherapeutics, Inc. Common Stock (ATRA) last sale data in real-time at NASDAQ.com. ATRA Atara Biotherapeutics — Stock Price and Discussion ... Real-time trade and investing ideas on Atara Biotherapeutics ATRA from the largest community of traders and investors. Market Data by Xignite and BATS BZX Real-Time Price. LLC. Member FINRA / SIPC. ST Invest is a wholly owned subsidiary of StockTwits, Inc. Investing in securities products involves risk, ATRA | Atara Biotherapeutics Inc. Stock Price & News - WSJ